SCHEMBL4355899

SCHEMBL4355899

O=C(NCCc1ccccc1)N(S)c1cccc(F)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.53
NPC1 O15118 4/20 0.53
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TAAR1 Q96RJ0 1/20 0.42
HTT P42858 1/20 0.41
EPHX1 P07099 1/20 0.41
PLAAT5 Q96KN8 2/20 0.41
PLAAT4 Q9UL19 2/20 0.41
PLAAT3 P53816 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346354 0.86 RAB9A (0.46) RAB9ANPC1CA12CA2CA9
SCHEMBL4356059 0.85 NPC1 (0.50) RAB9ANPC1CA12CA2CA9
SCHEMBL4350095 0.84 MAPT (0.46) RAB9ANPC1CA12CA2CA9
SCHEMBL4349030 0.82 RAB9A (0.49) RAB9ANPC1CA12CA2CA9
SCHEMBL4350070 0.80 NAAA (0.40) ALDH1A1SMN1; SMN2HTTEPHX1
SCHEMBL4347354 0.77 KMT2A (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2EPHX1
SCHEMBL4345395 0.76 CA1 (0.49) RAB9ANPC1CA2ALDH1A1SMN1; SMN2
SCHEMBL4341744 0.76 TRPV1 (0.46) RAB9ANPC1CA12CA2CA9
SCHEMBL6683265 0.76 RAB9A (0.44) RAB9ANPC1ADORA2AADORA1CYP1A2
SCHEMBL4348965 0.75 MMP1 (0.47) CA12CA2CA9ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 RAB9A 4228/4885NPC1 815/4885CA12 2054/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 RAB9A 4588/4885NPC1 1189/4885CA12 2458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.